Goller-Bulut D, Özcan G, Avci F. Changes in dimension of neurovascular canals in the mandible and maxilla: A radiographic finding in patients diagnosed with MRONJ. Med Oral Patol Oral Cir Bucal. 2018 May 1;23 (3):e282-9.
doi:10.4317/medoral.22274
http://dx.doi.org/doi:10.4317/medoral.22274
|
1.
Rosella D, Papi P, Giardino R, Cicalini E, Piccoli L, Pompa G.
Medication-related osteonecrosis of the jaw: Clinical and practical
guidelines. J Int Soc Prev Community Dent. 2016;6:97–104. |
|
|
|
|
|
2.
Arce K, Assael LA, Weissman JL, Markiewicz MR. Imaging findings in
bisphosphonate-related osteonecrosis of jaws. J Oral Maxillofac Surg. 2009;67:75-84. |
|
|
|
|
|
3.
Paulo S, Abrantes AM, Laranjo M, Carvalho L, Serra A, Botelho MF, Ferreira
MM. Bisphosphonate-related osteonecrosis of the jaw: specificities. Oncol Rev. 2014;8:254. |
|
|
|
|
|
4.
Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular
necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-7. |
|
|
|
|
|
5. Salvatore L.
Ruggiero DMD, Thomas B. et al. American Association of Oral
and Maxillofacial Surgeons position paper on bisphosphonate related
osteonecrosis of the jaws—2014 update. J Oral Maxillofac Surg.
2014;72:1938-1956. |
|
|
|
|
|
6.
Koth VS, Figueiredo MA, Salum FG, Cherubini K. Bisphosphonate-related
osteonecrosis of the jaw: from the sine qua non condition of bone exposure to
a non-exposed BRONJ entity. Dentomaxillofac
Radiol. 2016;45:20160049. |
|
|
|
|
|
7.
Torres SR, Chen CS, Leroux BG, Lee PP, Hollender LG, Schubert MM. Fractal
dimension Evaluation of cone beam computed tomography in patients with
bisphosphonate-associated osteonecrosis. Dentomaxillofac Radiol. 2011;40:501-5. |
|
|
|
|
|
8.
Senel FC, Kadioglu Duman M, Muci E, Cankaya M, Pampu AA, Ersoz S, Gunhan O.
Jaw bone changes in rats after treatment with zoledronate and pamidronate.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:385-91. |
|
|
|
|
|
9.
Migliorati CA. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol. 2003:21:4253-4. |
|
|
|
|
|
10. Marx RE, editor. Modes of action and pharmacokinetics of the bisphosphonate family. In: Oral and intravenous bisphosphonate- induced osteonecrosis of the jaws: history, etiology, prevention, and treatment. Hanover Park, IL: Quintessence Publishing; 2007. p. 11-5. |
|
|
|
|
|
11.
Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed
bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition,
prevention, and treatment. J
Oral Maxillofac Surg. 2005;63:1567-75. |
|
|
|
|
|
12.
Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of
the jaw: background and guidelines for diagnosis, staging and management.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:433-41. |
|
|
|
|
|
13.
Schirmer I, Peters H, Reichart PA, Dürkop H. Bisphosphonate und Osteonekrosen
im Kieferbereich [Bisphosphonates and osteonecrosis of the jaw]. Mund Kiefer Gesichtschir. 2005;9:239-45. |
|
|
|
|
|
14.
Bertoldo F, Santini D, Lo Cascio V. Bisphosphonates and osteomylelitis of the
jaw: a pathogenic puzzle. Nat
Clin Pract Oncol. 2007;4:711-21. |
|
|
|
|
|
15.
Bauss F, Pfister T, Pappapoulos S. Ibandronate uptake in the jaw is similar
to long bones and vertebrae in the rat. J Bone Miner Metab. 2008;26:406-8. |
|
|
|
|
|
16.
Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis of
the jaw caused by soft tissue toxicity? Bone. 2007;41:318-20. |
|
|
|
|
|
17.
Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005;353:99-102. |
|
|
|
|
|
18.
Rugani P, Luschin G, Jakse N, Kirnbauer B, Lang U, Acham S. Prevalence of
bisphosphonateassociated osteonecrosis of the jaw after intravenous
zoledronate infusions in patients with early breast cancer. Clin Oral Investig. 2014;18:401-7 |
|
|
|
|
|
19.
Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R. Clinical
and diagnostic imaging of bisphosphonate- associated osteonecrosis of the
jaws. Dentomaxillofac
Radiol. 2006;35:236-43. |
|
|
|
|
|
20.
Phal PM, Myall RW, Assael LA, Weissman JL. Imaging findings of
bisphosphonate-associated osteonecrosis of the jaws. AJNR Am J Neuroradiol.
2007;28:1139-45. |
|
|
|
|
|
21.
Bisdas S, Chambron Pinho N, Smolarz A, Sader R, Vogl TJ, Mack MG.
Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of
findings in 32 patients. Clin
Radiol. 2008;63:71-7. |
|
|
|
|
|
22.
Fleisher KE, Welch G, Kottal S, Craig RG, Saxena D, Glickman RS. Predicting
risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus
radiographic markers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2010;110:509-16. |
|
|
|
|
|
23.
Wilde F, Steinhoff K, Frerich B, Schulz T, Winter K, Hemprich A, et al.
Positron-emission tomography imaging in the diagnosis of
bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod. 2009;107:412–419. |
|
|
|
|
|
24.
Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et al.
Bisphosphonate associated osteonecrosis of the jaw: report of a task force of
the American Society for Bone and Mineral Research. J Bone Miner Res. 2007;22:1479-1491. |
|
|
|
|
|
25.
Torres SR, Chen CS, Leroux BG, Lee PP, Hollender LG, Santos EC, Drew SP, Hung
KC Schubert MM. Mandibular cortical bone evaluation on cone beam computed
tomography images of patients with bisphosphonate-related osteonecrosis of
the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:695-703. |
|